Development of Glycyrrhizinic Acid-Based Lipid Nanoparticle (LNP-GA) as An Adjuvant That Improves the Immune Response to Porcine Epidemic Diarrhea Virus Spike Recombinant Protein.

MLA

García-Cambrón, José Bryan, et al. “Development of Glycyrrhizinic Acid-Based Lipid Nanoparticle (LNP-GA) as An Adjuvant That Improves the Immune Response to Porcine Epidemic Diarrhea Virus Spike Recombinant Protein.” Viruses, vol. 16, no. 3, Mar. 2024. EBSCOhost, https://doi.org/10.3390/v16030431.

APA

García-Cambrón, J. B., Cerriteño-Sánchez, J. L., Lara-Romero, R., Quintanar-Guerrero, D., Blancas-Flores, G., Sánchez-Gaytán, B. L., Herrera-Camacho, I., & Cuevas-Romero, J. S. (2024). Development of Glycyrrhizinic Acid-Based Lipid Nanoparticle (LNP-GA) as An Adjuvant That Improves the Immune Response to Porcine Epidemic Diarrhea Virus Spike Recombinant Protein. Viruses, 16(3). https://doi.org/10.3390/v16030431

Chicago

García-Cambrón, José Bryan, José Luis Cerriteño-Sánchez, Rocío Lara-Romero, David Quintanar-Guerrero, Gerardo Blancas-Flores, Brenda L Sánchez-Gaytán, Irma Herrera-Camacho, and Julieta Sandra Cuevas-Romero. 2024. “Development of Glycyrrhizinic Acid-Based Lipid Nanoparticle (LNP-GA) as An Adjuvant That Improves the Immune Response to Porcine Epidemic Diarrhea Virus Spike Recombinant Protein.” Viruses 16 (3). doi:10.3390/v16030431.